| Type of support |
Approvals 2001-2023 (US$)(17 Sep 2019) |
Commitments 2001-2023 (US$)(17 Sep 2019) |
Disbursements 2000-2019 (US$)(17 Sep 2019) |
% Disbursed(17 Sep 2019) |
2002 |
2003 |
2004 |
2007 |
2011 |
2012 |
2013 |
2014 |
2015 |
2016 |
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
|---|
|
| Total |
$49,296,917 |
$62,897,069 |
$45,415,377 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Cold Chain Equipment Optimisation Platform (CCEOP) |
$2,625,972 |
$2,669,830 |
$2,621,473 |
100% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Health system strengthening (HSS 1) |
$13,130,191 |
$13,130,191 |
$13,130,191 |
100% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Health system strengthening (HSS 2) |
$12,631,706 |
$25,300,000 |
$8,581,705 |
68% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Immunisation services support (ISS) |
$1,218,000 |
$1,218,000 |
$1,218,000 |
100% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Injection Safety Devices (NVS) |
$277,176 |
$338,176 |
$350,110 |
126% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Injection safety support (INS) |
$210,140 |
$210,140 |
$210,140 |
100% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| IPV (NVS) |
$3,158,552 |
$3,158,552 |
$3,153,862 |
100% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Measles-Follow-up campaign (NVS) |
$872,500 |
$872,500 |
$910,029 |
104% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Measles-Follow-up campaign op.costs (OPC) |
$3,634,791 |
$3,634,791 |
$3,600,091 |
99% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Penta (NVS) |
$10,849,889 |
$11,676,889 |
$10,951,776 |
101% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Vaccine Introduction Grant (VIG) |
$688,000 |
$688,000 |
$688,000 |
100% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Red line on table indicates duration of support based on commitments.
Commitments: Multi-year programme budgets endorsed in principle by the Gavi Board. These become financial commitments upon approval each year for the following calendar year.
Approvals: Total Approved for funding
Download data for commitments, approvals & disbursements in XLS format